Byrne Asset Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68.7K | Sell |
543
-10
| -2% | -$1.27K | 0.05% | 185 |
|
|
2025
Q1 | $70.7K | Buy |
+553
| New | +$70.7K | 0.05% | 173 |
|
|
2024
Q4 | – | Sell |
-852
| Closed | -$124K | – | 159 |
|
|
2024
Q3 | $124K | Sell |
852
-32
| -4% | -$4.66K | 0.08% | 139 |
|
|
2024
Q2 | $122K | Sell |
884
-595
| -40% | -$82.1K | 0.09% | 140 |
|
|
2024
Q1 | $203K | Buy |
+1,479
| New | +$203K | 0.14% | 105 |
|
|
2023
Q4 | – | Sell |
-1,556
| Closed | -$190K | – | 110 |
|
|
2023
Q3 | $190K | Hold |
1,556
| – | – | 0.16% | 108 |
|
|
2023
Q2 | $198K | Buy |
1,556
+4
| +0.3% | +$509 | 0.13% | 145 |
|
|
2023
Q1 | $200K | Sell |
1,552
-52
| -3% | -$6.7K | 0.14% | 130 |
|
|
2022
Q4 | $211K | Buy |
1,604
+805
| +101% | +$106K | 0.15% | 128 |
|
|
2022
Q3 | $93K | Hold |
799
| – | – | 0.07% | 163 |
|
|
2022
Q2 | $94K | Sell |
799
-233
| -23% | -$27.4K | 0.07% | 146 |
|
|
2022
Q1 | $134K | Sell |
1,032
-49
| -5% | -$6.36K | 0.08% | 139 |
|
|
2021
Q4 | $165K | Buy |
+1,081
| New | +$165K | 0.11% | 122 |
|